dodecanol has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barth, T; Bergler, S; Büchele, B; Buckert, D; Buko, V; Diesinger, T; Dvorsky, R; Genze, F; Günes, C; Haehner, T; Haslbeck, M; Kirko, S; Kuchenbauer, F; Kumar, M; Lautwein, A; Masur, K; Müller-Enoch, D; Renz, C; Schneider, E; Simmet, T; Wirth, T | 1 |
1 other study(ies) available for dodecanol and Liver Neoplasms
| Article | Year |
|---|---|
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cytochrome P-450 CYP2E1; Dodecanol; Humans; Liver Neoplasms; Mice; Mice, Nude; Oxidative Stress | 2021 |